查看购物车
  • Traditional Chinese
  • English
  • Japanese
CHC 年鑑：2025
市场调查报告书
商品编码
1630468

CHC 年鑑：2025

CHC YearBook 2025
出版日期: | 出版商: Nicholas Hall Group of Companies | 英文 300 Pages | 订单完成后即时交付

价格
简介目录

它是消费者健康行销人员的重要资源，可即时取得支援快速且准确决策所需的关键事实和数据。

CHC 年鑑：2025包含整个 CHC 市场的全通路数据，包括商店销售、直销 (MLM) 和网路/邮购销售之间的划分。一些章节反映了专用资料库 "DB6" 的最新信息，并添加了透过这些管道销售的详细资讯。

CHC Almanac：2025被全球领先的 OTC、製药和消费者保健公司、投资银行和顾问公司使用。根据您的要求，该报告可透过各种数位授权（网站或全球）或单独的印刷版取得。

本报告提供了重点数据和分析，并借鉴了我们在消费者健康领域基准测试方面的丰富知识和经验。我们向您提供所有事实、所有数据。

世界评论

  • 它强调了关键发展和全球趋势，并预测了 CHC 的未来前景。

区域评论

  • 它涵盖八个主要地区并重点介绍主要市场、趋势和发展。

主要市场

  • 它涵盖15 个主要市场，按类别、主要行销人员和品牌提供顶级数据。以及各国法规、交换环境、广告和分销的评论

类别评论

  • 涵盖止痛药、CCA、GI、VMS、Derma和Lifestyle CHC。

主要公司

  • 全球前20大CHC公司概况及全球前250强销售额复合年增长率（2019-24）

併购

  • 涵盖2019 年以来的主要併购、合资和合作趋势，以及 CHC 产业的收购倍数

主要品牌

  • CHC 销售额排名前250 名的品牌 - 以及前25 个品牌的简要介绍

热门话题

  • 影响消费者健康的当前主题分析


Rx 到 OTC 转换

  • 主要市场转换环境概述 - 以及主要处方药到非处方药转换的概况


新产品开发与创新

  • CHC 类别的交付格式和目前 NPD 活动概述

全球零售趋势

  • 全面概述快速变化的全球零售格局


所需参考表

  • 有关成分分类、公司所有权、品牌和营销商、製造商协会以及CHC 词彙表的信息

目录

定义 CHC 市场

第1章 世界回顾

  • 世界概况
  • 竞争格局
  • 转变
  • 品牌与创新
  • 零售业
  • 外表

第2章 区域回顾

  • 北美
  • 东亚和东南亚
  • 西欧
  • 中欧/东欧
  • 拉丁美洲
  • 日本
  • 印度次大陆
  • 澳大拉西亚

第3章 主要市场

  • 美国
  • 中国
  • 日本
  • 德国
  • 印度
  • 义大利
  • 俄罗斯
  • 法国
  • 巴西
  • 英国
  • 波兰
  • 墨西哥
  • 加拿大
  • 澳洲
  • 印尼

第4章 分类审查

  • 止痛药
  • 咳嗽、感冒、过敏
  • 胃肠药
  • 维生素、矿物质和补充剂
  • 皮肤科
  • Lifestyle CHC

第5章 主要公司

  • Haleon
  • Kenvue
  • Bayer
  • Opella
  • P&G
  • Reckitt
  • China Resources 999
  • Taisho
  • Otsuka
  • Bausch Health
  • Abbott
  • Unilever
  • Nestle
  • Prestige Consumer Healthcare
  • Stada
  • Teva
  • Church &Dwight
  • Perrigo
  • Cooper Consumer Health
  • Alcon

第6章 併购

第7章 主要品牌

  • Vicks
  • Tylenol
  • Nature Made
  • Advil
  • Mucinex
  • Voltaren
  • Centrum
  • 999 Gan Mao Ling
  • Panadol
  • Halls
  • Nicorette
  • Dong-e E-Jiao
  • Nurofen
  • Zyrtec
  • Fupai E-Jiao
  • Claritin
  • Strepsils
  • Doliprane
  • Caltrate
  • Olly
  • Allegra
  • Nature's Bounty
  • Systane
  • Bayer Aspirin
  • Electrolit

第8章 热门话题

  • GLP-1 的使用为 CHC 球员提供了许多机会
  • 建议和社区营造对女性健康越来越重要
  • 消化健康趋势推动益生菌创新
  • 认知健康领域随着创新浪潮而扩展

第9章 从处方药转为非处方药

  • 概述
  • 西欧
  • 北美
  • 日本
  • 澳大拉西亚
  • 新兴市场
  • 重大转变
    • Allegra
    • Alli, Xenical
    • Astepro
    • Differin
    • Dymista
    • ellaOne
    • Flonase/Flixonase
    • Formigran
    • Hana, Lovima
    • Loxonin S
    • Maloff Protect
    • MiraLAX
    • Narcan
    • Nasacort
    • Nexium 24HR
    • Opill
    • Pataday
    • Plan B, NorLevo, Postinor, Levonelle
    • Prevacid 24HR
    • Silvasta、Maxon Active/Tadalafil MaxOn、Viagra Connect、Cialis
    • Voltaren
    • Xyzal
    • Zyrtec

第10章 新产品开发与创新

  • 止痛药
  • 咳嗽、感冒、过敏
  • 胃肠药
  • 维生素、矿物质和补充剂
  • 皮肤科
  • 生活方式CHC

第11章 全球零售趋势

第12章 公司所有权

第13章：品牌与行销人员

第14章 厂商会

第15章 词彙表

简介目录

CHC FACTS & FIGURES IN FOCUS

A vital resource for Consumer Health marketers, offering instant access to the key facts & figures needed to support quick and accurate decision-making, including full year-end 2024 sales data from the only dedicated worldwide CHC sales database.

Expansive channel coverage

"CHC YearBook 2025" includes All channels data for the total CHC market, including splits for Store, Direct (MLM) and Internet & mail order sales. Selected chapters feature added detail of sales via these channels, reflecting the latest information from our dedicated 'DB6' database.

"CHC YearBook" is used by top OTC, pharma and consumer health companies, investment banks and consultants around the world. Depending on your requirements, the report is available in various digital licences (Site or Global) or as individual print copies.

With extensive knowledge and experience in benchmarking the world of consumer health, Nicholas Hall's "CHC YearBook 2025" provides a focused set of data and analysis. Find all the facts, all the figures, at your fingertips.

Global Review

  • Highlighting major developments and global trends, and forecasting the CHC outlook for the future

Regional Review

  • 8 major regions come under the spotlight, with the focus on key markets, trends and developments

Leading Markets

  • Coverage of the Top 15 markets includes topline data by category, leading marketers and brands - PLUS a country-by-country review of regulations, switch environment, advertising and distribution

Category Review

  • Global coverage of Analgesics, CCA, Gastrointestinals, VMS, Derma and Lifestyle CHC

Leading Companies

  • Profiles of the Top 20 CHC players across the world. Leading 250 CHC marketers by sales with CAGR 2019-24

Mergers & Acquisitions

  • All the major M&A activity, joint-ventures and alliances since 2019 - PLUS coverage of multiples paid for acquisitions in the CHC industry

Leading Brands

  • The leading 250 CHC brands by sales - PLUS concise profiles of the Top 25 brands

Hot Topics

  • Analysis of the latest hot-button issues affecting consumer health


Rx-to-OTC Switch

  • Overview of the switch environment in key markets - PLUS profiles of significant Rx-to-OTC switches


New Product Development & Innovation

  • Overview of latest activity in delivery formats and NPD across CHC categories

Global Retailing

  • Comprehensive overview of the fast-changing global retailing environment


Essential Reference Tables

  • Information on classification of ingredients, company ownership, brands & marketers and manufacturers' associations - PLUS a CHC glossary

Table of Contents

CHC Market Definition

1. Global Review

  • World Overview
  • Competitive Landscape
  • Switch
  • Brands & Innovation
  • Retailing
  • Outlook

2. Regional Review

  • North America
  • East & South East Asia
  • Western Europe
  • Central & Eastern Europe
  • Latin America
  • Japan
  • Indian Subcontinent
  • Australasia

3. Leading Markets

  • USA
  • China
  • Japan
  • Germany
  • India
  • Italy
  • Russia
  • France
  • Brazil
  • UK
  • Poland
  • Mexico
  • Canada
  • Australia
  • Indonesia

4. Category Review

  • Analgesics
  • Cough, cold & allergy
  • Gastrointestinals
  • Vitamins, minerals & supplements
  • Dermatologicals
  • Lifestyle CHC

5. Leading Companies

  • Haleon
  • Kenvue
  • Bayer
  • Opella
  • P&G
  • Reckitt
  • China Resources 999
  • Taisho
  • Otsuka
  • Bausch Health
  • Abbott
  • Unilever
  • Nestle
  • Prestige Consumer Healthcare
  • Stada
  • Teva
  • Church & Dwight
  • Perrigo
  • Cooper Consumer Health
  • Alcon

6. Mergers & Acquisitions

7. Leading Brands

  • Vicks
  • Tylenol
  • Nature Made
  • Advil
  • Mucinex
  • Voltaren
  • Centrum
  • 999 Gan Mao Ling
  • Panadol
  • Halls
  • Nicorette
  • Dong-e E-Jiao
  • Nurofen
  • Zyrtec
  • Fupai E-Jiao
  • Claritin
  • Strepsils
  • Doliprane
  • Caltrate
  • Olly
  • Allegra
  • Nature's Bounty
  • Systane
  • Bayer Aspirin
  • Electrolit

8. Hot Topics

  • GLP-1 usage offers numerous opportunities for CHC players
  • Advice and community-building increasingly key in women's health
  • Trend for health through digestion driving innovation in probiotics
  • Rush of innovation expands cognitive health segment

9. Rx-to-OTC Switch

  • Overview
  • Western Europe
  • North America
  • Japan
  • Australasia
  • Emerging markets
  • The Big Switches
    • Allegra
    • Alli, Xenical
    • Astepro
    • Differin
    • Dymista
    • ellaOne
    • Flonase / Flixonase
    • Formigran
    • Hana, Lovima
    • Loxonin S
    • Maloff Protect
    • MiraLAX
    • Narcan
    • Nasacort
    • Nexium 24HR
    • Opill
    • Pataday
    • Plan B, NorLevo, Postinor, Levonelle
    • Prevacid 24HR
    • Silvasta, MaxOn Active / Tadalafil MaxOn, Viagra Connect, Cialis
    • Voltaren
    • Xyzal
    • Zyrtec

10. New Product Development & Innovation

  • Analgesics
  • Cough, Cold & Allergy
  • Gastrointestinals
  • Vitamins, Minerals & Supplements
  • Dermatologicals
  • Lifestyle CHC

11. Global Retailing

12. Company Ownership

13. Brands & Marketers

14. Manufacturers' Associations

15. Glossary

Charts

  • Chart 1: Global CHC sales by region 2024
  • Chart 2: Global CHC sales by category 2024
  • Chart 3: Global CHC forecasts by region
  • Chart 4: Global CHC forecasts by category
  • Chart 5: North America CHC market by category 2024
  • Chart 6: North America leading CHC marketers & brands 2024
  • Chart 7: E&SE Asia CHC market by category 2024
  • Chart 8: E&SE Asia leading CHC marketers & brands 2024
  • Chart 9: Western Europe CHC market by category 2024
  • Chart 10: Western Europe leading CHC marketers & brands 2024
  • Chart 11: C&E Europe CHC market by category 2024
  • Chart 12: C&E Europe leading CHC marketers & brands 2024
  • Chart 13: Latin America CHC market by category 2024
  • Chart 14: Latin America leading CHC marketers & brands 2024
  • Chart 15: Japan CHC market by category 2024
  • Chart 16: Japan leading CHC marketers & brands 2024
  • Chart 17: Indian Subcontinent CHC market by category 2024
  • Chart 18: Indian Subcontinent leading CHC marketers & brands 2024
  • Chart 19: Australasia CHC market by category 2024
  • Chart 20: Australasia leading CHC marketers & brands 2024
  • Chart 21: Global leading 15 CHC markets 2024
  • Chart 22: USA CHC market by category 2024
  • Chart 23: USA leading CHC marketers & brands 2024
  • Chart 24: China CHC market by category 2024
  • Chart 25: China leading CHC marketers & brands 2024
  • Chart 26: Japan CHC market by category 2024
  • Chart 27: Japan leading CHC marketers & brands 2024
  • Chart 28: Germany CHC market by category 2024
  • Chart 29: Germany leading CHC marketers & brands 2024
  • Chart 30: India CHC market by category 2024
  • Chart 31: India leading CHC marketers & brands 2024
  • Chart 32: Italy CHC market by category 2024
  • Chart 33: Italy leading CHC marketers & brands 2024
  • Chart 34: Russia CHC market by category 2024
  • Chart 35: Russia leading CHC marketers & brands 2024
  • Chart 36: France CHC market by category 2024
  • Chart 37: France leading CHC marketers & brands 2024
  • Chart 38: Brazil CHC market by category 2024
  • Chart 39: Brazil leading CHC marketers & brands 2024
  • Chart 40: UK CHC market by category 2024
  • Chart 41: UK leading CHC marketers & brands 2024
  • Chart 42: Poland CHC market by category 2024
  • Chart 43: Poland leading CHC marketers & brands 2024
  • Chart 44: Mexico CHC market by category 2024
  • Chart 45: Mexico leading CHC marketers & brands 2024
  • Chart 46: Canada CHC market by category 2024
  • Chart 47: Canada leading CHC marketers & brands 2024
  • Chart 48: Australia CHC market by category 2024
  • Chart 49: Australia leading CHC marketers & brands 2024
  • Chart 50: Indonesia CHC market by category 2024
  • Chart 51: Indonesia leading CHC marketers & brands 2024
  • Chart 52: Global CHC analgesics category split 2024
  • Chart 53: Leading analgesic brands 2024
  • Chart 54: Global CHC CCA category split 2024
  • Chart 55: Leading CCA brands 2024
  • Chart 56: Global CHC GIs category split 2024
  • Chart 57: Leading GI brands 2024
  • Chart 58: Global CHC VMS category split 2024
  • Chart 59: Leading VMS brands 2024
  • Chart 60: Global CHC dermatologicals category split 2024
  • Chart 61: Leading dermatological brands 2024
  • Chart 62: Global lifestyle CHC category split 2024
  • Chart 63: Leading lifestyle CHC brands 2024
  • Chart 64: Top 250 CHC marketers 2024
  • Chart 65: CHC merger, acquisition, alliance & joint-venture activity 2020-2025
  • Chart 66: Multiples paid for CHC acquisitions 2020-2024
  • Chart 67: Leading CHC brands 2024
  • Chart 68: Legal status of ingredients in selected world markets
  • Chart 69: Legal status of ingredients in selected European markets (I)
  • Chart 70: Legal status of ingredients in selected European markets (II)
  • Chart 71: Big Switches global CHC sales 2024
  • Chart 72: Company Ownership Index
  • Chart 73: Brands & Marketers Index